arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Cosmos Health Inc.

COSM
$0.23 ▲ +0.01 (+6.58%) at close
Healthcare ·Wholesale-Drugs, Proprietaries & Druggists' Sundries ·USWholesale-Drugs, Proprietaries & Druggists' Sundries
69 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
23
Health
Poor
Bearish
auto_awesome

Analytical Summary

Cosmos Health Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $10.8M
Dividend Yield
Revenue Growth 30.7%
Op. Margin -12.2%
ROIC -9.4%
FCF / Share $-0.02
Trailing P/E
Price / Book 0.5x
FCF Yield
Debt / Equity 0.17
info Valuation on last close. End-of-day price, Aug 7, 2026.

69-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$17.93M
↑ +30.7%
Net Income Profit after all expenses
$-2.81M
↓ -242.9%
Operating Margin Operating profit as % of sales
-12.2%
↑ +79.0% 9th
FCF / Share Free cash flow per share
$-0.02
↓ -199.9%
Long-Term Debt Long-term obligations
$3.45M
↓ -8.6%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
9
Returns
8
Financial Health
52
Cash Quality
37

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 69 quarters